| Title | [Conformal radiotherapy in prostate cancer: for whom and how?] | | Author(s) | Bey P, Beckendorf V, Aletti P, Marchesi V | | Institution | Département de radiothérapie, centre Alexis-Vautrin, avenue de Bourgogne, 54511 Vandoeuvre-Les-Nancy, France. p.bey@nancy.fnclcc.fr | | Source | Cancer Radiother 2002 May; 6(3):147-53. | | MeSH | Adenocarcinoma
Dose-Response Relationship, Radiation
English Abstract
Humans
Impotence
Intestines
Lymph Nodes
Male
Neoplasm Staging
Prostate
Prostatic Neoplasms
Radiation Injuries
Radiometry
Radiotherapy Dosage
Radiotherapy, Conformal
Risk
Seminal Vesicles
Urogenital System
| | Abstract | External radiotherapy is one of the modalities used to cure localized prostate carcinoma. Most of localized prostate carcinomas, specially those of the intermediate prognostic group, may benefit from escalated dose above 70 Gy at least as regard biochemical and clinical relapse free survival. 3D-CRT allows a reduction of the dose received by organs at risk and an increase of prostate dose over 70 Gy. It is on the way to become a standard. Intensity modulated radiation therapy increases dose homogeneity and reduces rectal dose. These methods necessitate rigorous procedures in reproducibility, delineation of volumes, dosimetry, daily treatment. They need also technological and human means. It is clear that localized prostate cancer is a good example for evaluation of these new radiotherapy modalities. | | Language | fre | | Pub Type(s) | Journal Article
Review
| | PubMed ID | 12116839 |
|
